News Releases Keyword Search Year None2026202520242023202220212020201920182017201620152014 May 28, 2026 Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences May 07, 2026 Rocket Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Recent Progress Apr 28, 2026 Rocket Pharmaceuticals Announces $180 Million Sale of Priority Review Voucher Mar 27, 2026 Rocket Pharmaceuticals Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I) Feb 26, 2026 Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress Feb 23, 2026 Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences Jan 05, 2026 Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference Print Page RSS E-mail Alerts Contact
Keyword Search Year None2026202520242023202220212020201920182017201620152014 May 28, 2026 Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences May 07, 2026 Rocket Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Recent Progress Apr 28, 2026 Rocket Pharmaceuticals Announces $180 Million Sale of Priority Review Voucher Mar 27, 2026 Rocket Pharmaceuticals Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I) Feb 26, 2026 Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress Feb 23, 2026 Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences Jan 05, 2026 Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference
May 07, 2026 Rocket Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Recent Progress
Mar 27, 2026 Rocket Pharmaceuticals Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)
Feb 26, 2026 Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress
Jan 05, 2026 Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference
